(3aR,3'aR,8aS,8'aS)-2,2'-(2-苯基-1-苄基亚乙基)双[3a,8a-二氢-8H-茚并[1,2-d]恶唑，≥98%

(3aR,3'aR,8aS,8'aS)-2,2'-[2-Phenyl-1-(phenylmethyl)ethylidene]bis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole

仅供研发或工业应用，不可直接用于食品、药品、临床诊断或治疗。